Big Pharma backed Bio-tech firm Synovex has reached the halfway mark for a planned $7m Series C round.
US Bio-tech firm Synovex Corp, has raised half of a planned $7m Series C round. The company did not reveal the identities of the investors who participated.
Synovex’s 2008 $12m Series B round included investments from pharmaceutical companies Amgen, GlaxoSmithKline and AstraZeneca, through their respective corporate venturing arms Amgen Ventures, SR One, and MedImmune Ventures , as well as returning Series A investors healthcare orientated venture capital firm Healthcare Ventures and the Harvard Partners Investments Fund, a collaborative fund…
